We are live on ! Find out more
NRXPW

NRX Pharmaceuticals Warrant
NRXPW

Delisted

NRXPW was delisted on the 22nd of May, 2026.

Back to rankings

2 hedge funds and large institutions have $4.28K invested in NRX Pharmaceuticals Warrant in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% less ownership

Funds ownership: 0.03% → 0.03% (-0%)

14% less capital invested

Capital invested by funds: $5K → $4.28K (-$716)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
YCM
1
Yakira Capital Management
Connecticut
$4.28K – – –

NRXPW Hedge Fund Activity: Q4 2022 in Review

2 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q4 2022, worth a combined $4.28K — down 14% from $5K a quarter earlier.

Fund positioning in NRXPW was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $4.28K of NRX Pharmaceuticals Warrant stock for Q4 2022, down 14% quarter-over-quarter.
  • 0 funds opened new NRX Pharmaceuticals Warrant positions in Q4 2022 and 0 closed out.

Based on aggregated 13F filings for Q4 2022.